Literature DB >> 21075109

Gallstone disease is associated with increased mortality in the United States.

Constance E Ruhl1, James E Everhart.   

Abstract

BACKGROUND & AIMS: Gallstones are common and contribute to morbidity and health care costs, but their effects on mortality are unclear. We examined whether gallstone disease was associated with overall and cause-specific mortalities in a prospective national population-based sample.
METHODS: We analyzed data from 14,228 participants in the third US National Health and Nutrition Examination Survey (20-74 years old) who underwent gallbladder ultrasonography from 1988 to 1994. Gallstone disease was defined as ultrasound-documented gallstones or evidence of cholecystectomy. The underlying cause of death was identified from death certificates collected through 2006 (mean follow-up, 14.3 years). Mortality hazard ratios (HR) were calculated using Cox proportional hazards regression analysis to adjust for multiple demographic and cardiovascular disease risk factors.
RESULTS: The prevalence of gallstones was 7.1% and of cholecystectomy was 5.3%. During a follow-up period of 18 years or more, the cumulative mortality was 16.5% from all causes (2389 deaths), 6.7% from cardiovascular disease (886 deaths), and 4.9% from cancer (651 deaths). Participants with gallstone disease had higher all-cause mortality in age-adjusted (HR = 1.3; 95% confidence interval [CI]: 1.2-1.5) and multivariate-adjusted analysis (HR = 1.3; 95% CI: 1.1-1.5). A similar increase was observed for cardiovascular disease mortality (multivariate-adjusted HR = 1.4; 95% CI: 1.2-1.7), and cancer mortality (multivariate-adjusted HR = 1.3; 95% CI: 0.98-1.8). Individuals with gallstones had a similar increase in risk of death as those with cholecystectomy (multivariate-adjusted HR = 1.1; 95% CI: 0.92-1.4).
CONCLUSIONS: In the US population, persons with gallstone disease have increased mortality overall and mortalities from cardiovascular disease and cancer. This relationship was found for both ultrasound-diagnosed gallstones and cholecystectomy.
Copyright © 2011 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 21075109      PMCID: PMC3060665          DOI: 10.1053/j.gastro.2010.10.060

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  22 in total

Review 1.  The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

Authors:  François R Jornayvaz; Varman T Samuel; Gerald I Shulman
Journal:  Annu Rev Nutr       Date:  2010-08-21       Impact factor: 11.848

2.  Blood lead below 0.48 micromol/L (10 microg/dL) and mortality among US adults.

Authors:  Andy Menke; Paul Muntner; Vecihi Batuman; Ellen K Silbergeld; Eliseo Guallar
Journal:  Circulation       Date:  2006-09-18       Impact factor: 29.690

3.  Gallbladder disease in the general population: association with cardiovascular morbidity and therapy.

Authors:  Antonio González-Pérez; Luis A García Rodríguez
Journal:  Pharmacoepidemiol Drug Saf       Date:  2007-05       Impact factor: 2.890

Review 4.  Gallstones.

Authors:  Grant Sanders; Andrew N Kingsnorth
Journal:  BMJ       Date:  2007-08-11

5.  A study of a possible association between breast cancer and gallbladder disease.

Authors:  D K Wysowski; E L Goldberg; G W Comstock; E L Diamond
Journal:  Am J Epidemiol       Date:  1986-03       Impact factor: 4.897

6.  Association of coffee consumption with gallbladder disease.

Authors:  C E Ruhl; J E Everhart
Journal:  Am J Epidemiol       Date:  2000-12-01       Impact factor: 4.897

Review 7.  Cholesterol gallstone disease.

Authors:  Piero Portincasa; Antonio Moschetta; Giuseppe Palasciano
Journal:  Lancet       Date:  2006-07-15       Impact factor: 79.321

8.  Cholelithiasis, cholecystectomy, and cancer: a case-control study in Sweden.

Authors:  A B Lowenfels; L Domellöf; C G Lindström; F Bergman; M A Monk; N H Sternby
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

9.  The association between cholesterol cholelithiasis and coronary heart disease in Framingham, Massachusetts.

Authors:  E A Bortnichak; D H Freeman; A M Ostfeld; W P Castelli; W B Kannel; M Feinleib; P M McNamara
Journal:  Am J Epidemiol       Date:  1985-01       Impact factor: 4.897

10.  Increased mortality with gallstone disease: results of a 20-year population-based survey in Pima Indians.

Authors:  C H Grimaldi; R G Nelson; D J Pettitt; R E Sampliner; P H Bennett; W C Knowler
Journal:  Ann Intern Med       Date:  1993-02-01       Impact factor: 25.391

View more
  53 in total

1.  Concept of the pathogenesis and treatment of cholelithiasis.

Authors:  Vasiliy Ivanovich Reshetnyak
Journal:  World J Hepatol       Date:  2012-02-27

2.  Pediatric obesity and gallstone disease.

Authors:  Corinna Koebnick; Ning Smith; Mary Helen Black; Amy H Porter; Bradley A Richie; Sharon Hudson; Deborah Gililland; Steven J Jacobsen; George F Longstreth
Journal:  J Pediatr Gastroenterol Nutr       Date:  2012-09       Impact factor: 2.839

3.  Effects of sphincter of Oddi motility on the formation of cholesterol gallstones.

Authors:  Zhong-Hou Rong; Hong-Yuan Chen; Xin-Xing Wang; Zhi-Yi Wang; Guo-Zhe Xian; Bang-Zhen Ma; Cheng-Kun Qin; Zhen-Hai Zhang
Journal:  World J Gastroenterol       Date:  2016-06-28       Impact factor: 5.742

4.  Economic and medical benefits of ultrasound screenings for gallstone disease.

Authors:  Hung-Ju Shen; Chung-Te Hsu; Tao-Hsin Tung
Journal:  World J Gastroenterol       Date:  2015-03-21       Impact factor: 5.742

5.  Hyperhomocysteinemia from trimethylation of hepatic phosphatidylethanolamine during cholesterol cholelithogenesis in inbred mice.

Authors:  Ji Zhang; Diane E Handy; Yufang Wang; Guylaine Bouchard; Jacob Selhub; Joseph Loscalzo; Martin C Carey
Journal:  Hepatology       Date:  2011-06-23       Impact factor: 17.425

6.  Polymorphisms in UGT1A1 Gene Predispose South Indians to Pigmentous Gallstones.

Authors:  Vishnubhotla Venkata Ravikanth; Guduru Venkat Rao; Bale Govardhan; Mitnala Sasikala; Chivukula Subramanyam; H V Vivekananda Murthy; Siddapuram Siva Prasad; G Deepika; Rebala Pradeep; Duvvuru Nageshwar Reddy
Journal:  J Clin Exp Hepatol       Date:  2016-08-30

7.  Diet-quality scores and the risk of symptomatic gallstone disease: a prospective cohort study of male US health professionals.

Authors:  Janine Wirth; Mingyang Song; Teresa T Fung; Amit D Joshi; Fred K Tabung; Andrew T Chan; Cornelia Weikert; Michael Leitzmann; Walter C Willett; Edward Giovannucci; Kana Wu
Journal:  Int J Epidemiol       Date:  2018-12-01       Impact factor: 7.196

8.  Outcome after percutaneous cholecystostomy for acute cholecystitis: a single-center experience.

Authors:  Yun-Cheng Hsieh; Chun-Ku Chen; Chien-Wei Su; Che-Chang Chan; Teh-Ia Huo; Chia-Jen Liu; Wen-Liang Fang; Kuei-Chuan Lee; Han-Chieh Lin
Journal:  J Gastrointest Surg       Date:  2012-07-25       Impact factor: 3.452

Review 9.  Recent Advances in the Critical Role of the Sterol Efflux Transporters ABCG5/G8 in Health and Disease.

Authors:  Helen H Wang; Min Liu; Piero Portincasa; David Q-H Wang
Journal:  Adv Exp Med Biol       Date:  2020       Impact factor: 2.622

10.  Does diabetes mellitus with or without gallstones increase the risk of gallbladder cancer? Results from a population-based cohort study.

Authors:  Hsueh-Chou Lai; Shih-Ni Chang; Che-Chen Lin; Ching-Chou Chen; Jen-Wei Chou; Cheng-Yuan Peng; Shih-Wei Lai; Fung-Chang Sung; Yu-Fen Li
Journal:  J Gastroenterol       Date:  2012-10-16       Impact factor: 7.527

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.